NANOPARTICLE DELIVERY OF INTEGRIN-SPECIFIC SIRNAS AS TARGETED THERAPY TO ALLEVIATE TRIPLE-NEGATIVE BREAST CANCER (TNBC) METASTASIS

Case Western Reserve University, Cleveland OH

Investigators